Shortage reports
Actual shortage:
65 (10%)
Anticipated shortage:
15 (2%)
Avoided shortage:
16 (2%)
Resolved:
570 (86%)
666
Discontinuation Reports
To be discontinued:
7 (10%)
Discontinued:
54 (75%)
Reversed:
11 (15%)
72
52 (7%)
17 (20%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 800MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232020 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 100MG | CAPSULE | Anticipated shortage | 2026-03-30 | 2026-03-30 | 281855 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-05-28 | 2024-10-08 | 228997 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-08 | 2021-02-10 | 119747 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2025-04-01 | 2025-06-14 | 253778 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-13 | 2024-04-04 | 219378 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-11 | 2021-02-10 | 114761 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-11-01 | 2026-01-06 | 241793 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-26 | 2024-05-29 | 223456 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2026-01-06 | 223453 |
| HYDROCHLOROTHIAZIDE | 50MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229804 |
| IMATINIB | 100MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225711 |
| IMATINIB | 400MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225714 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2024-11-25 | 2025-12-09 | 243736 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 | ||
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73239 | ||
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73236 | ||
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-10-12 | 264958 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-08-12 | 264961 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111527 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-10-27 | 2025-10-28 | 270365 |
| PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79465 |
| PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79468 |
| PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79471 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |